| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 596 | 2017 |
| Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder JH Min, BJ Kim, KH Lee Multiple Sclerosis Journal 18 (1), 113-115, 2012 | 338 | 2012 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 191 | 2019 |
| Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study D Adams, M Polydefkis, A González-Duarte, J Wixner, AV Kristen, ... The Lancet Neurology 20 (1), 49-59, 2021 | 124 | 2021 |
| Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica SM Kim, P Waters, A Vincent, SY Kim, HJ Kim, YH Hong, KS Park, JH Min, ... Multiple Sclerosis Journal 15 (9), 1062-1068, 2009 | 103 | 2009 |
| The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders SY Huh, JH Min, W Kim, SH Kim, HJ Kim, BJ Kim, BJ Kim, KH Lee Multiple Sclerosis Journal 20 (6), 695-704, 2014 | 99 | 2014 |
| Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica JH Min, HJ Kim, BJ Kim, KW Lee, IN Sunwoo, SM Kim, BJ Kim, SH Kim, ... Multiple Sclerosis Journal 15 (9), 1069-1076, 2009 | 96 | 2009 |
| Long‐term safety and efficacy of Eculizumab in Aquaporin‐4 IgG‐positive NMOSD DM Wingerchuk, K Fujihara, J Palace, A Berthele, M Levy, HJ Kim, ... Annals of neurology 89 (6), 1088-1098, 2021 | 74 | 2021 |
| Transcranial Doppler ultrasonographic evaluation of vertebral artery hypoplasia and aplasia JH Min, YS Lee Journal of the neurological sciences 260 (1-2), 183-187, 2007 | 74 | 2007 |
| Electrophysiological features of patients with POEMS syndrome JH Min, YH Hong, KW Lee Clinical neurophysiology 116 (4), 965-968, 2005 | 74 | 2005 |
| Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial JH Min, YH Hong, JJ Sung, SM Kim, JB Lee, KW Lee Journal of Korean medical science 27 (2), 200-206, 2012 | 71 | 2012 |
| Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: a multicenter retrospective study in Korea JM Seok, HJ Cho, SW Ahn, EB Cho, MS Park, IS Joo, HY Shin, SY Kim, ... Multiple Sclerosis Journal 23 (13), 1748-1756, 2017 | 69 | 2017 |
| Prevalence of multiple sclerosis in Korea NH Kim, HJ Kim, HK Cheong, BJ Kim, KH Lee, EH Kim, EA Kim, S Kim, ... Neurology 75 (16), 1432-1438, 2010 | 69 | 2010 |
| Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life JM Seok, M Choi, EB Cho, HL Lee, BJ Kim, KH Lee, P Song, EY Joo, ... PloS one 12 (5), e0177230, 2017 | 50 | 2017 |
| Factors associated with quality of life of people with Myasthenia Gravis A Jeong, JH Min, YK Kang, J Kim, M Choi, JM Seok, BJ Kim PLoS One 13 (11), e0206754, 2018 | 48 | 2018 |
| Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability JH Min, P Waters, A Vincent, HJ Cho, BE Joo, SY Woo, SY Lee, HY Shin, ... PLoS One 9 (9), e107274, 2014 | 44 | 2014 |
| The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism Y Kim, JM Seok, J Park, KH Kim, JH Min, JW Cho, S Park, H Kim, BJ Kim, ... PLoS One 12 (7), e0180744, 2017 | 43 | 2017 |
| Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder JH Park, J Hwang, JH Min, BJ Kim, ES Kang, KH Lee Journal of the Neurological Sciences 348 (1-2), 132-135, 2015 | 42 | 2015 |
| Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder E Kang, JH Min, KH Lee, BJ Kim Annals of laboratory medicine 32 (5), 331-338, 2012 | 42 | 2012 |
| White matter network disruption and cognitive dysfunction in neuromyelitis optica spectrum disorder EB Cho, CE Han, SW Seo, J Chin, JH Shin, HJ Cho, JM Seok, ST Kim, ... Frontiers in neurology 9, 1104, 2018 | 39 | 2018 |
